{"created_at":"Wed Dec 03 21:01:41 +0000 2014","id":540249537139732481,"id_str":"540249537139732481","text":"$AMGN Blincyto FDA accelerated app'l on P2 r\/r adult ALL trial; 1' endpt=CR+CRh* rate (43%; mOS 6.1mo at #ASCO2014) #biotech #leukemia","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2483984858,"id_str":"2483984858","name":"Jolene Lau","screen_name":"BMTJolene","location":"San Diego","url":"http:\/\/www.biomedtracker.com","description":"Chemical Biologist.  Scientific Analyst at BioMedTracker.","protected":false,"verified":false,"followers_count":104,"friends_count":119,"listed_count":6,"favourites_count":3,"statuses_count":531,"created_at":"Thu May 08 15:56:11 +0000 2014","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/474217834084438017\/UuHL2Zm8_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/474217834084438017\/UuHL2Zm8_normal.jpeg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"ASCO2014","indices":[105,114]},{"text":"biotech","indices":[116,124]},{"text":"leukemia","indices":[125,134]}],"trends":[],"urls":[],"user_mentions":[],"symbols":[{"text":"AMGN","indices":[0,5]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en","timestamp_ms":"1417640501662"}
{"created_at":"Wed Dec 03 00:02:03 +0000 2014","id":539932540010631170,"id_str":"539932540010631170","text":"Nasdaq100 #Stocks Performance $TRIP $BIIB $ALXN $NFLX $REGN $STX $MXIM $QCOM $VRTX $MU $AMGN $GILD $SPLS  more@ http:\/\/t.co\/YdSIjGiCGR","source":"\u003ca href=\"http:\/\/12stocks.com\" rel=\"nofollow\"\u003edozenstocks\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":567452784,"id_str":"567452784","name":"12Stocks.com","screen_name":"DozenStocks","location":"Orlando, FL","url":"http:\/\/12Stocks.com","description":"Click your way to best performing stocks. http:\/\/t.co\/zXe5du8n, http:\/\/t.co\/x4mB2xW2, http:\/\/t.co\/lp4DGOl8, http:\/\/t.co\/sv9RJYDo, http:\/\/t.co\/Bm7xqtU1 & more @","protected":false,"verified":false,"followers_count":735,"friends_count":7,"listed_count":32,"favourites_count":0,"statuses_count":26751,"created_at":"Mon Apr 30 16:54:56 +0000 2012","utc_offset":-14400,"time_zone":"Atlantic Time (Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/2901055623\/0b59fed3be5c8fe0d681848529e987f1_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/2901055623\/0b59fed3be5c8fe0d681848529e987f1_normal.jpeg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"Stocks","indices":[10,17]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/YdSIjGiCGR","expanded_url":"http:\/\/12Stocks.com\/QQQQ","display_url":"12Stocks.com\/QQQQ","indices":[112,134]}],"user_mentions":[],"symbols":[{"text":"TRIP","indices":[30,35]},{"text":"BIIB","indices":[36,41]},{"text":"ALXN","indices":[42,47]},{"text":"NFLX","indices":[48,53]},{"text":"REGN","indices":[54,59]},{"text":"STX","indices":[60,64]},{"text":"MXIM","indices":[65,70]},{"text":"QCOM","indices":[71,76]},{"text":"VRTX","indices":[77,82]},{"text":"MU","indices":[83,86]},{"text":"AMGN","indices":[87,92]},{"text":"GILD","indices":[93,98]},{"text":"SPLS","indices":[99,104]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en","timestamp_ms":"1417564923657"}
{"created_at":"Wed Dec 03 20:50:09 +0000 2014","id":540246634698137600,"id_str":"540246634698137600","text":"$AMGN - FDA Approves BLINCYTO\u2122 (Blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory http:\/\/t.co\/Y1avpCJVya","source":"\u003ca href=\"http:\/\/www.advfn.com\" rel=\"nofollow\"\u003eADVFN News Alert\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":1228272776,"id_str":"1228272776","name":"Rachel Smith","screen_name":"racheloduk","location":"","url":null,"description":null,"protected":false,"verified":false,"followers_count":1,"friends_count":1,"listed_count":0,"favourites_count":3,"statuses_count":106491,"created_at":"Thu Feb 28 19:55:51 +0000 2013","utc_offset":0,"time_zone":"Casablanca","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"080808","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"2B60DE","profile_sidebar_border_color":"000000","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":false,"profile_image_url":"http:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_3_normal.png","profile_image_url_https":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_3_normal.png","default_profile":false,"default_profile_image":true,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/Y1avpCJVya","expanded_url":"http:\/\/uk.advfn.com\/news\/PRNUS\/2014\/article\/64659667?xref=newsalerttweet&adw=1126416","display_url":"uk.advfn.com\/news\/PRNUS\/201\u2026","indices":[104,126]}],"user_mentions":[],"symbols":[{"text":"AMGN","indices":[0,5]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en","timestamp_ms":"1417639809666"}
